Nuo Therapeutics
(OTC) AURX
Nuo Therapeutics Financials at a Glance
Market Cap
$82.09M
Revenue (TTM)
$3.31M
Net Income (TTM)
$2.51M
EPS (TTM)
$-0.05
P/E Ratio
-31.95
Dividend
$0.00
Beta (Volatility)
-37.86 (Low)
Dividend
$0.00
Beta (Volatility)
-37.86 (Low)
Price
$1.70
Volume
10
Open
$1.58
Price
$1.70
Volume
10
Open
$1.58
Previous Close
$1.70
Daily Range
$1.58 - $1.70
52-Week Range
$0.94 - $3.23
Dividend
$0.00
Beta (Volatility)
-37.86 (Low)
Price
$1.70
Volume
10
Open
$1.58
Previous Close
$1.70
Daily Range
$1.58 - $1.70
52-Week Range
$0.94 - $3.23
AURX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
David Emerson Jorden, CFA, MBA
Website
www.nuot.comHeadquarters
Houston, TX 77054, US
AURX Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-76%
Net Income Margin
-76%
Return on Equity
-1032%
Return on Capital
-5%
Return on Assets
-1%
Earnings Yield
-3.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$82.09M
Shares Outstanding
48.29M
Volume
10
Short Interest
0.00%
Avg. Volume
3.80K
Financials (TTM)
Gross Profit
$2.22M
Operating Income
$2.52M
EBITDA
$2.36M
Operating Cash Flow
$864.97K
Capital Expenditure
$274.76K
Free Cash Flow
$1.14M
Cash & ST Invst.
$548.95K
Total Debt
$97.35K
Nuo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.10M
+177.8%
Gross Profit
$688.37K
+123.2%
Gross Margin
62.76%
N/A
Market Cap
$82.09M
N/A
Market Cap/Employee
$9.12M
N/A
Employees
9
N/A
Net Income
$578.48K
-16.5%
EBITDA
$663.90K
-10.5%
Quarterly Fundamentals
Net Cash
$451.60K
+277.9%
Accounts Receivable
$561.67K
+126.3%
Inventory
$213.76K
+42.1%
Long Term Debt
$20.94K
-78.5%
Short Term Debt
$76.41K
+14.3%
Return on Assets
-1.36%
N/A
Return on Invested Capital
-4.67%
N/A
Free Cash Flow
$465.85K
+5.0%
Operating Cash Flow
$422.65K
+13.8%